Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Alimta
Active Ingredient: Pemetrexed sodium 713mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Lilly France S.A.S, Fegersheim, France
Product: Requip (follow-on pack)
Active Ingredient: Ropinirole hydrochloride 0.57mg equivalent to ropinirol 0.5mg
Dosage Form: 0.5mg Film coated tablet
Active Ingredient: Ropinirole hydrochloride 1.14mg equivalent to ropinirol 1mg
Dosage Form: 1mg Film coated tablet
Active Ingredient: Ropinirole hydrochloride 2.28mg equivalent to ropinirol 2mg
Dosage Form: 2mg Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: SmithKline Beecham Plc, Magpie Wood, Manor Royal, Crawley, Sussex, United Kingdom
Product: Requip (starter pack)
Active Ingredient: Ropinirole hydrochloride 0.285mg equivalent to ropinirol 0.25mg
Dosage Form: 0.25mg Film coated tablet
Active Ingredient: Ropinirole hydrochloride 0.57mg equivalent to ropinirol 0.5mg
Dosage Form: 0.5mg Film coated tablet
Active Ingredient: Ropinirole hydrochloride 1.14mg equivalent to ropinirol 1mg
Dosage Form: 1mg Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: SmithKline Beecham Plc, Magpie Wood, Manor Royal, Crawley, Sussex, United Kingdom
Dated this 26th day of July 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).